“To provide menstruating patients with sickle cell disease the best care, primary care physicians, gynecologists, and ...

Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...

Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Sickle cell disease causes excruciating pain and damage to the body. But now there are new treatments that can put an end to ...

Administration of opioid medications to people who present to the ED with acute sickle cell disease pain often does not happen as quickly as guidelines recommend, data presented at ASH Annual Meeting ...

Key Takeaways U.S. emergency rooms aren’t providing prompt treatment for sickle cell pain crisisOnly 1 in 3 patients get ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle ...

Guideline adherence for opioid pain medications was found to be suboptimal among patients with sickle cell disease pain in the ED.

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle cell disease received appropriate opioid-based pain-relieving medications ...

The guidelines also differ in the follow-up assessment of patients while they are in the emergency room. The NHLBI also recommends reassessing patients every 15 to 30 minutes and readministering pain ...